Melanoma risk is higher than usual during pregnancy and the 6 months thereafter, but women with postcancer pregnancies have good survival rates.
The effect of gestation on cancer has been hotly debated for decades, and the issue, as it relates to melanoma, remains a tremendous concern for dermatologists. Investigators performed a retrospective, population-based cohort study based on linked data from the Norwegian cancer and birth registries. The researchers analyzed cause-specific survival when cancer was diagnosed during pregnancy or the lactation period (~6 months postpartum) and in women with postcancer pregnancies.
Of 42,511 eligible women of childbearing age with a cancer diagnosis, 41,464 were not pregnant, 516 were pregnant, and 531 were in the lactating/postpartum period. Despite breast cancer being the most frequent diagnosis in this age group, malignant melanoma was the mos…
Reviewing Author
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)
DisclosuresConsultant / advisory board Lubax; WorldCare Clinical
EquityLubax
Grant / Research support NIH; Department of Defense; American Skin Association; Piramal
Editorial boardsBritish Journal of Dermatology; Journal of the American Academy of Dermatology; Journal of Investigative Dermatology
Leadership positions in professional societies American Academy of Dermatology (Chair, Skin Cancer and Melanoma Committee); American Board of Dermatology (Director)